Results 21 to 30 of about 108 (104)
Prognosis and prevention of cardioembolic stroke in patients with atrial fibrillation
Медицинский совет, 2013 The article is a review of literature on the prognosis and prevention of stroke in patients with atrial fibrillation (AF). It is noted that the simple CHA2DS2-VASc calculator is a good predictor of the risk of stroke in AF.
V. А. Parfyonov, S. V. Verbitskaya
doaj +1 more source
ПРОБЛЕМА ВНУТРИЧЕРЕПНЫХ КРОВОИЗЛИЯНИЙ НА ФОНЕ ПРИЕМА «НОВЫХ» АНТИ КОАГУЛЯНТОВ
Атеротромбоз, 2014 Высокая распространенность тромботических осложнений у пациентов с сердечно-сосудистыми заболеваниями обусловила широкое применение в клинической практике антикоагулянтной терапии. Длительное время основным антикоагулянтом, применяемым по этим показаниям,
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Data on the problem of thromboembolic complications in non-valvular atrial fibrillation are presented. Peculiarities of anticoagulant therapy to prevent thromboembolic complications, the difficulties in drug choice and dosage adjustment are also ...
E. L. Dolgova +2 more
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Aim. To compare direct medical costs of dabigatran and warfarin therapy in patients with non-valvular atrial fibrillation (NVAF) during preparation for elective cardioversion. Material and methods.
L. E. Kuvshinova +3 more
doaj +1 more source
COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS
Рациональная фармакотерапия в кардиологии, 2015 Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban, an oral inhibitor of Xa factor, nowadays can be considered as a drug with very good safety profile according to randomized trials results and performed ...
V. A. Sulimov +2 more
doaj +1 more source
The problem of choosing an anticoagulant for stroke prevention in patients with atrial fibrillation
Медицинский совет, 2014 The article is a literature review on the problem of thromboembolic complications in non-valvular atrial fibrillation, the peculiarities of anticoagulant therapy and challenges associated with the selection of drugs for stroke prevention.
EL Dolgova, IM Sokolov, YG Schwarz
doaj +1 more source
, 2022 The COVID-19 epidemic is accompanied by an increase in the frequency of rhythm disturbances and, in particular, atrial fibrillation. This article is a clinical analysis of a patient whose atrial fibrillation (fluttering) occurred due to an infection ...
E. P. Panchenko +1 more
core +1 more source
NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
Рациональная фармакотерапия в кардиологии, 2015 Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including dabigatran, rivaroxaban and apixaban) is presented from the standpoint of safety.
D. A. Napalkov, A. A. Sokolova
doaj +1 more source
ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
Рациональная фармакотерапия в кардиологии, 2016 New data and perspectives of antithrombotic therapy are highlighted in patients with atrial fibrillation. Factors of warfarin therapy efficacy, as well as the possibility of new antithrombotic drugs are considered.
M. Yu. Gilyarov, V. A. Sulimov
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2015 The clinical significance of the patient genetic characteristics in the individual pharmacological response to oral anticoagulants is considered. Possible tactics of warfarin dosing and new oral anticoagulants choice on the basis of pharmacogenetic ...
D. A. Sychev +3 more
doaj +1 more source